Company Overview and News

 
Apple, Procter & Gamble Sink the Dow Thursday

2018-04-20 247wallst
April 19, 2018: Markets opened lower Thursday for the first time in five days. Absent an significant economic news, investors and traders were looking earnings results that have been good, but just not good enough to justify some high valuations. 10-year Treasury yields were back above 2.9% for a while today too.
Upvote Downvote

 
DowDuPont (DWDP) Plans to Invest $100M in Facility Expansion

2018-04-16 zacks
Our experts cut down 220 Zacks Rank #1 Strong Buys to the 7 most likely to jump in price immediately.
Upvote Downvote

 
Intel, Boeing Pace Dow Gains on Thursday

2018-04-12 247wallst
April 12, 2018: Markets opened higher Thursday following another good report on new claims for unemployment benefits and an apparent softening of Trump’s promise of a military strike against Syria. With several big banks reporting first quarter earnings Friday, investors appear to be upbeat about the coming earnings season.
Upvote Downvote

 
Boeing, DowDuPont Sink the Dow Wednesday

2018-04-11 247wallst
April 11, 2018: Markets opened lower Wednesday and the blue chippers spent the entire day trading in the red. The tech-heavy Nasdaq popped in to the green for much of the day but was losing ground in the last hour and the S&P 500 was also trading down. Trump’s comments related to missiles raining down on Syria made for a subdued start to the day while the CPI report was not strong enough to overcome the geopolitics.
Upvote Downvote

 
Boeing, Caterpillar Dominate the Dow Tuesday

2018-04-10 247wallst
April 10, 2018: Markets opened higher again Tuesday and, like Monday, the leading indexes managed to build on their early gains to stay in the green all day. Comments from China’s Xi Jinping indicating he would increase imports, speed up access to the country’s financial sector, do more to protect intellectual property, and lower tariffs and ease restrictions on car ownership all added up to smiles on Wall Street today.
Upvote Downvote

 
DowDuPont's (DWDP) Unit Launches New Choozit Products Range

2018-04-10 zacks
Our experts cut down 220 Zacks Rank #1 Strong Buys to the 7 most likely to jump in price immediately.
Upvote Downvote

 
Approval for Bayer, Monsanto Merger Could Plow US Farmers Under

2018-04-10 247wallst
The $60-billion deal that allows Bayer to acquire Monsanto Co. (NYSE: MON) reportedly received antitrust approval late Monday from the U.S. Justice Department after the two companies agreed to dispose of additional, as-yet unspecified assets.
Upvote Downvote

 
Snap Is Going Nowhere - Cramer's Lightning Round (4/9/18)

2018-04-10 seekingalpha
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, April 9.
Upvote Downvote

 
DWDP / DowDuPont Inc. DEFA14A

2018-04-09 sec.gov
DEFA14A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Upvote Downvote

 
FMC - Lithium's Not Kryptonite

2018-04-09 seekingalpha
We believe FMC (NYSE:FMC) presents an attractive longer term investment given its very accretive transaction with DowDupont (DWDP). The company has leading market share and continues to invest in the ag chem business. FMC also continues to target a Lithium listing in 3Q/4Q and a full separation of the business in 1Q19. We think it’s a good time to buy FMC, despite some investors feeling concerned about lithium oversupply.
Upvote Downvote

 
General Electric Doesn’t Relinquish Rank as Dow’s Worst Performing Stock

2018-04-07 247wallst
General Electric Co. (NYSE: GE) was not the worst performing Dow stock last week, but the shares dropped more than 3%, enough to virtually cement GE’s place as the index’s worst performer of the year to date. Shares are down about 25.2% so far in 2018.
Upvote Downvote

1
Dow 30 Stock Roundup: Boeing Wins $8.8B Order From Jet Airways, GE Sells Health IT to Veritas for $1.05B

2018-04-06 zacks
The Dow rebounded strongly this week after trade war fears receded and tech stocks staged a recovery. Markets declined on Monday after uncertainty over a prospective trade war weighed on investor sentiment. However, the Dow registered strong gains over the next three trading days, registering its first three-session stretch of gains since Feb 26.
Upvote Downvote

 
US-China Trade Dispute: The Ultimate Stock Showdown!

2018-04-06 zacks
The tariff dispute, which has been playing spoilsport, has intensified with President Donald Trump’s latest rhetoric on a potential trade war with China. Trump is seeking a further tariff of $100 billion against China in addition to the already proposed $50 billion of tariffs on Chinese goods, targeting robotics, information technology, communication technology and aerospace. Earlier this week, Washington planned to slap a 25% tariff on 1,300 China-made products, which include a wide array of products including raw materials, construction machinery, agricultural equipment, electronics, medical devices and consumer goods.
Upvote Downvote

 
Will Trade Tussle Take a Bite Out of US Petrochemical Boom?

2018-04-06 zacks
The shale gas revolution in the United States has been a huge driving force behind chemical investments in plants and equipment in the country. And currently, the U.S. petrochemical industry is in the middle of a shale-induced investment boom leveraging access to abundant and cheaper feedstocks. However, the escalating trade tensions between Washington and Beijing is expected to play spoilsport. President Donald Trump, who has a record of attacking China for unfair trade practices, recently proposed sweeping tariffs on $50 billion of imports from China.
Upvote Downvote

 
Boeing, Chevron Lead Dow Higher on Thursday

2018-04-05 247wallst
April 5, 2018: Markets opened higher Thursday as traders began to see that only the first shots of a trade war have been fired and that no tariffs are likely to be imposed for as long as six months. The non-farm payroll report is out tomorrow morning and another solid gain is expected. That should get investors and traders focused in on quarterly earnings results that will begin hitting the tape next week.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 260543103